BioSpace News Archive

Deals

FSD Pharma Reports 2018 Year-End Results

FSD Pharma Inc. reported its financial and operational results for the fourth quarter and fiscal year-ended December 31, 2018.

May 6, 2019
·
6 min read
Drug Development

Can-Fite Announces Preparation for End-of-Phase II Meeting with FDA to Initiate the Phase III Liver Cancer Study for Namodenoson

Fast Track and Orphan Drug Status; No treatment currently exists for advanced liver cancer patients in whom the current standard of care does not work

May 6, 2019
·
7 min read
Job Trends

Deep Learning Chipset Shipments to Increase to 2.9 Billion Units Annually by 2025, According to Tractica

GPUs and CPUs Currently Lead in Market Share, but ASICs will Capture the Lead by 2022, with Expanded Opportunities for SoC Accelerators and FPGAs

May 6, 2019
·
3 min read
BioMidwest

Patient Rights at the Center of a New Report by Dr. Nalini M. Rajamannan

The final clues are falling into place in a 12-year-old mystery about how patient protections were bypassed during open heart surgery for hundreds of patients and published in the American Association of Thoracic Surgeons Journal.

May 6, 2019
·
3 min read
Policy

HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Cancer

Patent expected to issue coincident with HedgePath’s 2019 efforts to clear IND for SUBA®-Itraconazole for the treatment of prostate cancer

May 6, 2019
·
5 min read
Biotech Bay

Vynca and South Carolina Coalition for the Care of the Seriously Ill Collaborate to Enhance End-of-life Care

Vynca, a provider of advance care planning solutions, and the South Carolina Coalition for the Care of the Seriously Ill have collaborated to implement Vynca’s advance care planning technology to enhance end-of-life care for patients.

May 6, 2019
·
5 min read
SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care

Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company to accelerate product development and begin next phase clinical studies in Europe, the US and China

May 6, 2019
·
2 min read
FDA

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

New Stent System Now Available for Treating Patients with Deep Venous Blockages

May 6, 2019
·
5 min read
Pharm Country

U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease

First and only medicines approved for patients with either wild-type or hereditary transthyretin amyloid cardiomyopathy

May 6, 2019
·
12 min read
Schools teach music, math and coding--why not empathy, tenacity and self-esteem?

Canadian Mental Health Association calls for new mental health promotion strategy to get out in front of mental illness.

May 6, 2019
·
4 min read